GLP-1 Family intermediate
GLP-1 Agonist Gastric Safety
Safety profile of GLP-1 receptor agonists regarding gastric emptying, gastroparesis, and gastrointestinal tolerability.
By Encyclopeptide Editorial | 1 min read
GLP-1 gastric-safety gastroparesis tolerability GI-effects
Gastrointestinal Tolerability
Nausea
- Incidence: 20-40% during dose titration
- Resolution: Typically within 4-8 weeks
- Management: Slow titration, dietary modification
Vomiting
- Incidence: 5-15%
- Timing: Usually early in treatment
Gastroparesis Considerations
- Pre-existing gastroparesis is relative contraindication
- GLP-1 agonists may exacerbate symptoms
- Monitor for delayed gastric emptying signs
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 Agonist Gastric Safety |
| Category | GLP-1 Family |
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “GLP-1 Agonist Gastric Safety” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about GLP-1 Agonist Gastric Safety with interactive quizzes on Wikipept.
Take a Quiz on Wikipept